NTRK3 Is a Potential Tumor Suppressor Gene Commonly Inactivated by Epigenetic Mechanisms in Colorectal CancerYanxin Luo, William M. Grady|PLoS Genetics|2013Cited by 110
Silence of a dependence receptor CSF1R in colorectal cancer cells activates tumor-associated macrophagesMingxuan Zhu, Yanxin Luo, Liangliang Bai et al.|Journal for ImmunoTherapy of Cancer|2022Cited by 55
Erectile and urinary function in men with rectal cancer treated by neoadjuvant chemoradiotherapy and neoadjuvant chemotherapy alone: a randomized trial reportMeijin Huang, Jianping Wang, Jinxin Lin et al.|International Journal of Colorectal Disease|2016Cited by 34
Radiomic signature of the FOWARC trial predicts pathological response to neoadjuvant treatment in rectal cancerZhuokai Zhuang, Yanxin Luo, Juan Li et al.|Journal of Translational Medicine|2021Cited by 23
Time to lowest postoperative carcinoembryonic antigen level is predictive on survival outcome in rectal cancerHuichuan Yu, Jianping Wang, Yanxin Luo et al.|Scientific Reports|2016Cited by 6